These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16728750)

  • 1. Risk factors for tobacco dependence in adolescent smokers.
    Karp I; O'Loughlin J; Hanley J; Tyndale RF; Paradis G
    Tob Control; 2006 Jun; 15(3):199-204. PubMed ID: 16728750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.
    O'Loughlin J; Paradis G; Kim W; DiFranza J; Meshefedjian G; McMillan-Davey E; Wong S; Hanley J; Tyndale RF
    Tob Control; 2004 Dec; 13(4):422-8. PubMed ID: 15564629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
    Schoedel KA; Hoffmann EB; Rao Y; Sellers EM; Tyndale RF
    Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.
    Chenoweth MJ; Sylvestre MP; Contreras G; Novalen M; O'Loughlin J; Tyndale RF
    Drug Alcohol Depend; 2016 Jan; 158():139-46. PubMed ID: 26644138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analytic review of the CYP2A6 genotype and smoking behavior.
    Carter B; Long T; Cinciripini P
    Nicotine Tob Res; 2004 Apr; 6(2):221-7. PubMed ID: 15203795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption.
    Tyndale RF; Pianezza ML; Sellers EM
    Nicotine Tob Res; 1999; 1 Suppl 2():S63-7; discussion S69-70. PubMed ID: 11768189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CYP2A6 in the emergence of nicotine dependence in adolescents.
    Audrain-McGovern J; Al Koudsi N; Rodriguez D; Wileyto EP; Shields PG; Tyndale RF
    Pediatrics; 2007 Jan; 119(1):e264-74. PubMed ID: 17130279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.
    Fujieda M; Yamazaki H; Saito T; Kiyotani K; Gyamfi MA; Sakurai M; Dosaka-Akita H; Sawamura Y; Yokota J; Kunitoh H; Kamataki T
    Carcinogenesis; 2004 Dec; 25(12):2451-8. PubMed ID: 15308589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures of nicotine dependence enhance interpretation of number of cigarettes smoked in youth smoking surveillance.
    Dugas EN; Sylvestre MP; Wellman RJ; Winickoff J; Montreuil A; O'Loughlin J
    Drug Alcohol Depend; 2019 Nov; 204():107534. PubMed ID: 31493751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing risk factors for the onset of cravings, withdrawal symptoms and tolerance in novice adolescent smokers.
    Wileyto P; O'Loughlin J; Lagerlund M; Meshefedjian G; Dugas E; Gervais A
    Tob Control; 2009 Oct; 18(5):387-92. PubMed ID: 19648131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association of CYP2A6 genotype and smoking topography.
    Strasser AA; Malaiyandi V; Hoffmann E; Tyndale RF; Lerman C
    Nicotine Tob Res; 2007 Apr; 9(4):511-8. PubMed ID: 17454707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
    Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
    Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2A6 gene polymorphism and personality traits for NEO-FFI on the smoking behavior of youths.
    Waga C; Iwahashi K
    Drug Chem Toxicol; 2007; 30(4):343-9. PubMed ID: 17934923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
    Ariyoshi N; Miyamoto M; Umetsu Y; Kunitoh H; Dosaka-Akita H; Sawamura Y; Yokota J; Nemoto N; Sato K; Kamataki T
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):890-4. PubMed ID: 12223434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Benowitz NL
    Clin Pharmacol Ther; 2008 Apr; 83(4):531-41. PubMed ID: 18305452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation of genetic variants of CYP2A6 with tobacco dependence and smoking habit in Chilean subjects. A pilot study].
    Cáceres DD; Alvarado SA; Martínez P; Quiñones LA
    Rev Med Chil; 2012 Apr; 140(4):436-41. PubMed ID: 22854688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Electronic Cigarette Dependence Among Youth and Its Association With Future Use.
    Vogel EA; Cho J; McConnell RS; Barrington-Trimis JL; Leventhal AM
    JAMA Netw Open; 2020 Feb; 3(2):e1921513. PubMed ID: 32074292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk.
    Tyndale RF; Sellers EM
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):548-52. PubMed ID: 11259349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.